imidacloprid has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauch, C; Bennekou, SH; Blum, J; Danker, T; Ecker, GF; Forsby, A; Gardner, I; Grillberger, K; Haufe, Y; Hinojosa, MG; Johansson, Y; Kraushaar, U; Leist, M; Loser, D; Möller, C; Nicke, A; Walker, P | 1 |
| Casida, JE; Tomizawa, M | 1 |
2 other study(ies) available for imidacloprid and Neuroblastoma
| Article | Year |
|---|---|
Acute effects of the imidacloprid metabolite desnitro-imidacloprid on human nACh receptors relevant for neuronal signaling.
Topics: Alkenes; Animals; Cell Line; Cell Line, Tumor; Humans; Imidazolines; Molecular Docking Simulation; Neonicotinoids; Neuroblastoma; Neurons; Nicotinic Agonists; Nitro Compounds; Oocytes; Pesticides; Pyridines; Receptors, Nicotinic; Signal Transduction; Xenopus laevis | 2021 |
Desnitro-imidacloprid activates the extracellular signal-regulated kinase cascade via the nicotinic receptor and intracellular calcium mobilization in N1E-115 cells.
Topics: Animals; Calcium; Calcium Channels; Dose-Response Relationship, Drug; Imidazoles; Insecticides; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Neonicotinoids; Neuroblastoma; Nicotine; Nitro Compounds; Plants; Receptors, Nicotinic; Tumor Cells, Cultured | 2002 |